California Lab Develops Drug-Free Approach to Climax Control

LOS ANGELES - While the FDA has not yet approved dapoxetine, a pill to help curb premature ejaculation, Zurich Medical Labs has designed Prematrol, a drug-free approach to the problem.

"The need remains to develop libido products that are suitable alternatives to drugs and not only help men last longer and offer the chance at healthy, satisfying sex lives, but are safe and detached of potentially harmful side effects," said W. Baclini, founder of Zurich Medical Labs.

Marketed under the brand name Priligy, dapoxetine has been approved for medical use in Sweden and Finland, but was rejected for use at this time by the FDA.

Responding to the unmet need for an effective, scientifically proven home remedy for quick climax, Zurich Medical Labs developed Prematrol as a safe, drug-free approach to help achieve better control and male sexual health. Prematrol uses an advanced blend of naturally potent ingredients known to influence serotonin and believed to prolong orgasm.  

An estimated 30 million adult men in the United States endure problems with premature ejaculation, a condition thought to affect up to 30 percent of the male population worldwide. Health experts attribute lack of climax control to low levels of naturally produced brain chemical serotonin.

Dapoxetine is among a class of selective serotonin reuptake inhibitor (SSRI) drugs that include antidepressants which are widely used to stimulate production of serotonin to last longer in bed.

"The problem isn't just that this kind of artificial solution for premature ejaculation cure remains inaccessible in the U.S., it's the inherent risks tied to this solution for how to last longer in bed," Baclini said.

For more information, visit Prematrol4Men.com. For retail and wholsesale opportunities, email [email protected].